BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →
vpside

NEUP

Neuphoria Therapeutics Inc.
Nasdaq · Pharmaceutical preparations (SIC 2834) · FY ends 30 Jun

Revenue, quarterly

−$13267
$20M$10M$0−$10M
Q2 ’25Q3 ’25Q4 ’25
Company filings · 10-K filed 29 Sept 2025 · Q4 = FY − 9Mvpside.com

Gross margin, trailing twelve months

—
Not reported in this company’s filings
Company filingsvpside.com

Cash and cash equivalents, quarter-end

$20M+39.8% year on year
$30M$20M$10M$0
Q1 ’25Q3 ’25Q1 ’26Q2 ’26Q4 ’26
Company filings · 10-K filed 18 Sept 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

—
Not reported in this company’s filings
Company filingsvpside.com
Chart 05 is empty
Chart 06 is empty